Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Andlauer Healthcare Group Inc T.AND

Alternate Symbol(s):  ANDHF

Andlauer Healthcare Group Inc. is a Canada-based supply chain management company. The Company offers a robust platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector. Its 3PL services include customized logistics, distribution and packaging solutions for healthcare manufacturers across Canada. Its specialized transportation services in Canada, including air freight forwarding, ground transportation, dedicated delivery and last-mile services, provide a one-stop shop for clients' healthcare transportation needs. It operates in two segments: Specialized Transportation and Healthcare Logistics. Through its complementary service offerings, available across a coast-to-coast distribution network, it strives to accommodate the full range of its clients' specialized supply chain needs. The Company also provides specialized ground transportation services, primarily to the healthcare sector, across the 48 contiguous U.S. states.


TSX:AND - Post by User

Post by retiredcfon Nov 19, 2021 2:43pm
120 Views
Post# 34147340

Earnings Assessment

Earnings Assessment

AND reported EPS of $0.31, missing estimates of $0.3283, and revenue of $104.2M missing estimates of $104.5M. Revenue increased by 37.5% year-over-year. The company's COVID-19 vaccine-related revenue made up approximately 2.5% of revenue compared with 5% in the previous quarter. The company issued shares for $168.7M and used some of the proceeds to pay for the acquisition of T.F. Boyle Transportation and the remaining 51% of Skelton USA. In doing so, the company has now increased its presence in the US greatly, and while the company missed on both revenue and earnings, they were fairly minor misses. We continue to like the company, and the reduced dependence on transportation of COVID-19 related vaccines gives us more comfort in the stickiness and longevity of AND's revenue growth. 


So said the team at 5iResearch. And as you may have assumed by now, I have recently opened a position. GLTA

<< Previous
Bullboard Posts
Next >>